Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥27.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥117.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥28.3bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥2.9bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥4.1bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥4.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥17.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.9bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥4.3bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥4.9bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.0bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥3.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥3.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥226.5bnat 2022-06-30Cons.Assets
Total assets¥229.0bnat 2022-03-31Cons.Assets
Total assets¥222.0bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2022-06-30Cons.Liabilities
Total liabilities¥41.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥189.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥187.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥180.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥72.6bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥75.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥21.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.932021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.662021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥796m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥790m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥17m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥369m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥3.1bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.0bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥56m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥194m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥354m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥1.8bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥7m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-06-30¥26.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥26.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥419m
—segment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥27.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥425m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥795m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥735m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥59m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥19m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥543m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥543m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥385m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2021-04-01 → 2021-06-30¥4.5bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.4bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥99m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2021-04-01 → 2021-06-30¥141m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.0bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥11.6bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥376m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2021-04-01 → 2021-06-30¥11.5bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.5bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥8m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.1bn
—segment totalrevenue2021-04-01 → 2021-06-30¥28.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥27.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥483m
—segment totalsegment profit2021-04-01 → 2021-06-30¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥28.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥28.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥543m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥4.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 408
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)PwCあらた有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)川 原 光 爵
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)那 須 伸 裕
Cpa3 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)八 木  正  憲
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration28255000000JPY
Net sales (5-year summary)CurrentYTDDuration27255000000JPY
Net sales (5-year summary)Prior1YearDuration117752000000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration4932000000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration4156000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration17003000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration3017000000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration2493000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration9046000000JPY
Comprehensive income (5-year summary)Prior1YTDDuration5591000000JPY
Comprehensive income (5-year summary)CurrentYTDDuration5919000000JPY
Comprehensive income (5-year summary)Prior1YearDuration15372000000JPY
Net assets (5-year summary)Prior1QuarterInstant180439000000JPY
Net assets (5-year summary)CurrentQuarterInstant189032000000JPY
Net assets (5-year summary)Prior1YearInstant187673000000JPY
Total assets (5-year summary)Prior1QuarterInstant221987000000JPY
Total assets (5-year summary)CurrentQuarterInstant226524000000JPY
Total assets (5-year summary)Prior1YearInstant228982000000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration25.66
Basic earnings loss per share (5-year summary)CurrentYTDDuration21.39
Basic earnings loss per share (5-year summary)Prior1YearDuration76.93
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.695
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.707
Equity to asset ratio (5-year summary)Prior1YearInstant0.700
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember132604524
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember132604524
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant132604524
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant132604524
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember12354400
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember8394900
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1118105
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember111810500
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember44724
Number of shares issued shares voting rightsCurrentQuarterInstant132604524
Number of voting rights issued shares voting rightsCurrentQuarterInstant1118105
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member12354400
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass